Up a level |
(2021) Bacteriocins: Recent advances in application as an antimicrobial alternative. Curr Pharm Biotechnol. ISSN 1389-2010
(2021) Safety and efficacy of Favipiravir in moderate to severe SARS-CoV-2 pneumonia. International Immunopharmacology. p. 8. ISSN 1567-5769